Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders

Informations

• Publié par: Elsevier
• Nombre de lectures: 5
• Langue: English

Extrait

Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders PR Newswire PHILADELPHIA, June 7, 2012

PHILA DELPHIA,June 7, 2012/PRNewswire/ -- Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Society for Vascular Surgery® announce the launch of a new quarterly journal,Journal of Vascular Surgery: Venous and Lymphatic Disorders. The inaugural issue will appear in January, 2013. Elsevier currently publishes theJournal of Vascular Surgery® on behalf of the Society. "We are extremely pleased to be working with Elsevier to publish a new peer-reviewed journal specifically designed to promote venous and lymphatic health," commented Richard Cambria, MD, President of the Society for Vascular Surgery. "A collaborative effort between the Society for Vascular Surgery and the American Venous Forum, theJournal of Vascular Surgery: Venous and Lymphatic Disorderswill provide a valuable channel for the dissemination of important research and clinical information in this rapidly evolving field." Journal of Vascular Surgery: Venous and Lymphatic Disorderswill publish high quality clinical and basic scientific research, case reports, venous images, techniques, review articles, and practice management manuscripts related to all aspects of venous disease, lymphatic disease, and wound care with an emphasis on the practicing clinician. The journal will seek to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals who treat patients presenting with venous and lymphatic disease. The distinguished international editorial board will be led by Anton N. Sidawy, MD, and Bruce A. Perler, MD. "Venous disease is highly prevalent and is a significant cause of morbidity and mortality," stated Dr. Sidawy. "It is our goal to publish high-quality clinical studies, research, case reports, techniques, reviews, venous and lymphatic images, and practice management manuscripts related to all aspects of venous disease, lymphatic disease, and wound care."

NOTES FOR EDITORS About the editors

A ntonN. Sidawy, MD, is Professor and Chairman of the Department of Surgery at the George Washington University in Washington, D.C.He is the Editor-in-Chief of theJournal of Vascular Surgeryand Past-President of the Society for Vascular Surgery, the Society for Clinical Vascular Surgery, and the Eastern Vascular Society. Bruce A. Perler, MD, MBA, is chief of the division of vascular surgery and professor of surgery at Johns Hopkins Medicine, Baltimore, MD. He is the Senior Editor of theJournal of Vascular Surgeryand Past President of the Eastern Vascular Society and the Southern Association for Vascular Surgery.

About the Society for Vascular Surgery (SVS)

The Society for Vascular Surgery® (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health through education, advocacy, research, and public awareness. SVS is the national advocate for 3,550 specialty-trained vascular surgeons and other medical professionals who are dedicated to the prevention and cure of vascular disease. http://www.vascularweb.org

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, includingThe LancetandCell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered inA msterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). Media contact Jayne Dawkins Elsevier [phone] [e-mail]